15 September 2023: Aker BioMarine ASA (“Aker BioMarine” or “the company”) informs that its krill harvesting vessels have all returned to shipyard for scheduled upgrades and maintenance.
Total volumes year to date of 2023 were 49,800 MT, which is at the same level as the 49,500 MT produced in the same period last year. The vessels operated for another week before going to shipyard last year, for a total catch of 50,100 MT prior to shipyard.
The company expects the vessels to be back on fishing ground in Antarctica during the second half of November 2023. Based on historical daily catch volumes after shipyard, the company remains on track to deliver on a normalized harvesting year.
For further information, please contact
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820
Email: Christopher.vinter@akerbiomarine.com
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.